Nobuyoshi M - Search Results

1

Homopiperazine derivatives as a novel class of proteasome inhibitors with a unique mode of proteasome binding.

Kikuchi J, Shibayama N, Yamada S, Wada T, Nobuyoshi M, Izumi T, Akutsu M, Kano Y, Sugiyama K, Ohki M, Park SY, Furukawa Y. Kikuchi J, et al. Among authors: nobuyoshi m. PLoS One. 2013 Apr 11;8(4):e60649. doi: 10.1371/journal.pone.0060649. Print 2013. PLoS One. 2013. PMID: 23593271 Free PMC article.

2

Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma.

Kikuchi J, Wada T, Shimizu R, Izumi T, Akutsu M, Mitsunaga K, Noborio-Hatano K, Nobuyoshi M, Ozawa K, Kano Y, Furukawa Y. Kikuchi J, et al. Among authors: nobuyoshi m. Blood. 2010 Jul 22;116(3):406-17. doi: 10.1182/blood-2009-07-235663. Epub 2010 Mar 29. Blood. 2010. PMID: 20351311 Free article.

3

The novel orally active proteasome inhibitor K-7174 exerts anti-myeloma activity in vitro and in vivo by down-regulating the expression of class I histone deacetylases.

Kikuchi J, Yamada S, Koyama D, Wada T, Nobuyoshi M, Izumi T, Akutsu M, Kano Y, Furukawa Y. Kikuchi J, et al. Among authors: nobuyoshi m. J Biol Chem. 2013 Aug 30;288(35):25593-25602. doi: 10.1074/jbc.M113.480574. Epub 2013 Jul 22. J Biol Chem. 2013. PMID: 23878197 Free PMC article. Clinical Trial.

4

Bortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma.

Noborio-Hatano K, Kikuchi J, Takatoku M, Shimizu R, Wada T, Ueda M, Nobuyoshi M, Oh I, Sato K, Suzuki T, Ozaki K, Mori M, Nagai T, Muroi K, Kano Y, Furukawa Y, Ozawa K. Noborio-Hatano K, et al. Among authors: nobuyoshi m. Oncogene. 2009 Jan 15;28(2):231-42. doi: 10.1038/onc.2008.385. Epub 2008 Oct 13. Oncogene. 2009. PMID: 18850009

5

Effect of glucocorticoids on the biologic activities of myeloma cells: inhibition of interleukin-1 beta osteoclast activating factor-induced bone resorption.

Ishikawa H, Tanaka H, Iwato K, Tanabe O, Asaoku H, Nobuyoshi M, Yamamoto I, Kawano M, Kuramoto A. Ishikawa H, et al. Among authors: nobuyoshi m. Blood. 1990 Feb 1;75(3):715-20. Blood. 1990. PMID: 2297574 Free article.

6

Altered expression of Pax-5 gene in human myeloma cells.

Mahmoud MS, Huang N, Nobuyoshi M, Lisukov IA, Tanaka H, Kawano MM. Mahmoud MS, et al. Among authors: nobuyoshi m. Blood. 1996 May 15;87(10):4311-5. Blood. 1996. PMID: 8639790 Free article.

7

Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma.

Kawano M, Tanaka H, Ishikawa H, Nobuyoshi M, Iwato K, Asaoku H, Tanabe O, Kuramoto A. Kawano M, et al. Among authors: nobuyoshi m. Blood. 1989 Jun;73(8):2145-8. Blood. 1989. PMID: 2786435 Free article.

8

Sensitive inhibitory effect of interferon-alpha on M-protein secretion of human myeloma cells.

Tanaka H, Tanabe O, Iwato K, Asaoku H, Ishikawa H, Nobuyoshi M, Kawano M, Kuramoto A. Tanaka H, et al. Among authors: nobuyoshi m. Blood. 1989 Oct;74(5):1718-22. Blood. 1989. PMID: 2790196 Free article.

9

Interleukin-1 beta rather than lymphotoxin as the major bone resorbing activity in human multiple myeloma.

Kawano M, Yamamoto I, Iwato K, Tanaka H, Asaoku H, Tanabe O, Ishikawa H, Nobuyoshi M, Ohmoto Y, Hirai Y, et al. Kawano M, et al. Among authors: nobuyoshi m. Blood. 1989 May 1;73(6):1646-9. Blood. 1989. PMID: 2785413 Free article.

10

Homotypic cell aggregations of human myeloma cells with ICAM-1 and LFA-1 molecules.

Kawano MM, Huang N, Tanaka H, Ishikawa H, Sakai A, Tanabe O, Nobuyoshi M, Kuramoto A. Kawano MM, et al. Among authors: nobuyoshi m. Br J Haematol. 1991 Dec;79(4):583-8. doi: 10.1111/j.1365-2141.1991.tb08085.x. Br J Haematol. 1991. PMID: 1685327

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters